Palabras clave:
Tipos de documento
Novedades
Endocrinología Página 1 de 1
Guías de práctica clínica |
|
Año: 2020
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes.
|
|
Año: 2019
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
|
Artículos valorados críticamente |
|
Año: 2023
Perdikidis Olivieri L, Ortega Páez E. Evid Pediatr. 2023;19:29
Artículo original: Cartanyà Hueso A, Lidón Moyano C, Martín Sánchez JC, González Marrón A, Pérez Martín H, Martínez Sánchez JM. Association between recreational screen time and excess weight and obesity assessed with three sets of criteria in Spanish residents aged 2-14 years. An Pediatr (Engl Ed). 2022 Nov;97(5):333-41.
|
|
Año: 2023
Rivero Martín MJ, Lojo Pons P. Evid Pediatr. 2023;19:17
Artículo original: Rodprasert W, Koskenniemi JJ, Virtanen HE, Sadov S, Perheentupa A, Ollila H, et al. Reproductive Markers of Testicular Function and Size During Puberty in Boys With and Without a History of Cryptorchidism. J Clin Endocrinol Metab. 2022; 107:3353-3361.
|
|
Año: 2023
Ochoa Sangrador C, Aparicio Rodrigo M. Evid Pediatr. 2023;19:14
Artículo original: Ganmaa D, Bromage S, Khudyakov P, Erdenenbaatar S, Delgererekh B, Martineau AR. Influence of Vitamin D Supplementation on Growth, Body Composition, and Pubertal Development Among School-aged Children in an Area With a High Prevalence of Vitamin D Deficiency. A Randomized Clinical Trial. JAMA Pediatr 2023;177:32-41.
|
|
Año: 2023
Rivero Martín MJ, Fraile Astorga G. Evid Pediatr. 2023;19:2
Artículo original: Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher Berry C, Barrientos Pérez M, et al; AWARD-PEDS Investigators. Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes. N Engl J Med. 2022;387:433-43.
|
|
Año: 2022
Balado Insunza MN, Ochoa Sangrador C. Evid Pediatr. 2022;18:25
Artículo original: Akcan N, Uysalol M, Kandemir I, Soydemir D, Abali ZY, Poyrazoglu S, et al. Evaluation of the efficacy and safety of 3 different management protocols in pediatric diabetic ketoacidosis. Pediatr Emerg Care. 2021; 37:e707-12.
|
|
Año: 2022
Pérez-Moneo Agapito B, Cuestas Montañés EJ. Evid Pediatr. 2022;18:34
Artículo original: Gupta K, Amboiram P, Balakrishnan U, Ashok C, Abiramalatha T, Devi U. Dextrose Gel for Neonates at Risk with Asymptomatic Hypoglycemia: A Randomized Clinical Trial. Pediatrics. 2022;149:e2021050733.
|
|
Año: 2022
Molina Arias M, Aparicio Rodrigo M. Evid Pediatr. 2022;18:39
Artículo original: Mank E, Sáenz de Pipaón M, Lapillonne A, Carnielli VP, Senterre T, Shamir R, et al. Efficacy and safety of enteral recombinant human insulin in preterm infants: A randomized clinical trial. JAMA Pediatr. 2022;176:452-60.
|
|
Año: 2020
Molina Arias M, Rivero Martín MJ. Evid Pediatr. 2020;16:49
Artículo original: Eckert-Lind C, Busch AS, Petersen JH, Biro FM, Butler G, Bräuner EV, et al. Worldwide Secular Trends in Age at Pubertal Onset Assessed by Breast Development Among Girls: A Systematic Review and Meta-analysis. JAMA Pediatr. 2020;174:e195881.
|
|
Año: 2020
Aparicio Rodrigo M, Rivero Martín MJ. Evid Pediatr. 2020;16:31
Artículo original: Turban JL, King D, Carswell JM, Keuroghlian AS. Pubertal suppression for transgender youth and risk of suicidal ideation. Pediatrics. 2020;145:e20191725.
|
Otros |
|
Año: 2020
Down syndrome is phenotypically variable, but programs have been introduced to capitalize on each person’s best abilities. Guidelines for surveillance of the many associated medical problems and guidance for managing problems that are unique to Down syndrome are available.
|
Página 1 de 1, mostrando 12 de un total de 12